Table 3.
Comparison of the asymptomatic and symptomatic subgroups
| Asymptomatic Subgroup n = 56 | Symptomatic Subgroup n = 11 | p-value | |
|---|---|---|---|
| Mean age y (±SD) | 56,7 (12.5) | 53,6 (12.3) | p = 0.45 |
| Sex (m/f) | 38/18 | 10/1 | p = 0.12 (X2 = 2.405) |
| Type of surgery (n=) | |||
| PPPD | n = 43 | n = 5 | p = 0.10 (X2 = 4.515) |
| Whipple | n = 8 | n = 4 | |
| Other | n = 5 | n = 2 | |
| Associated disease (n=) | |||
| PDAC | n = 10 | n = 2 | p = 0.05 (X2 = 10.47) |
| CP | n = 18 | n = 7 | |
| Cystic neoplasia | n = 11 | n = 0 | |
| NET | n = 6 | n = 0 | |
| AP | n = 9 | n = 0 | |
| Other | n = 2 | n = 2 | |
| Heinrich Type | |||
| I | 26 | 6 | p = 0.88 (X2 = 0.2428) |
| II | 24 | 4 | |
| III | 6 | 1 |
PDAC pancreatic ductal adenocarcinoma, CP chronic pancreatitis, NET neuroendocrine tumor